HomeMAIA • NYSEAMERICAN
add
Maia Biotechnology Inc
$1.71
Makalipas ang Oras ng Trabaho:(8.77%)+0.15
$1.86
Sarado: May 23, 6:58:56 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Nakaraang pagsara
$1.79
Sakop ng araw
$1.71 - $1.82
Sakop ng taon
$1.40 - $5.99
Market cap
51.83M USD
Average na Volume
297.62K
P/E ratio
-
Dividend yield
-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 5.43M | 37.39% |
Net na kita | -4.52M | 44.01% |
Net profit margin | — | — |
Kita sa bawat share | -0.16 | 65.22% |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 10.86M | 31.33% |
Kabuuang asset | 11.86M | 36.12% |
Kabuuang sagutin | 6.92M | -52.20% |
Kabuuang equity | 4.94M | — |
Natitirang share | 29.59M | — |
Presyo para makapag-book | 10.53 | — |
Return on assets | -123.19% | — |
Return on capital | -316.27% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Net na kita | -4.52M | 44.01% |
Cash mula sa mga operasyon | -4.20M | -17.16% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 5.46M | 15.78% |
Net change in cash | 1.26M | 12.60% |
Malayang cash flow | -2.61M | -20.72% |
Tungkol
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells. Wikipedia
Itinatag
2018
Headquarters
Website
Mga Empleyado
13